206 related articles for article (PubMed ID: 12503650)
1. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.
Solomon T; Hart CA; Vinjamuri S; Beeching NJ; Malucci C; Humphrey P
J Child Neurol; 2002 Sep; 17(9):703-5. PubMed ID: 12503650
[TBL] [Abstract][Full Text] [Related]
2. Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): international multicenter study.
Gascon GG;
J Child Neurol; 2003 Dec; 18(12):819-27. PubMed ID: 14736075
[TBL] [Abstract][Full Text] [Related]
3. [Therapy and prognosis in subacute sclerosing panencephalitis].
Hosoya M
Nihon Rinsho; 2007 Aug; 65(8):1483-6. PubMed ID: 17695288
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon.
Anlar B; Yalaz K; Oktem F; Köse G
Neurology; 1997 Feb; 48(2):526-8. PubMed ID: 9040751
[TBL] [Abstract][Full Text] [Related]
5. [Subacute sclerosing panencephalitis: combined treatment with interferon alpha and intraventricular ribavirin].
del Toro-Riera M; Macaya-Ruiz A; Raspall-Chaure M; Tallada-Serra M; Pasqual-López I; Roig-Quilis M
Rev Neurol; 2006 Mar 1-15; 42(5):277-81. PubMed ID: 16538590
[TBL] [Abstract][Full Text] [Related]
6. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis.
Yalaz K; Anlar B; Oktem F; Aysun S; Ustacelebi S; Gurcay O; Gucuyener K; Renda Y
Neurology; 1992 Mar; 42(3 Pt 1):488-91. PubMed ID: 1372397
[TBL] [Abstract][Full Text] [Related]
7. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis.
Gascon G; Yamani S; Crowell J; Stigsby B; Nester M; Kanaan I; Jallu A
Brain Dev; 1993; 15(5):346-55. PubMed ID: 7506498
[TBL] [Abstract][Full Text] [Related]
8. Combined interferon-alpha and inosiplex treatment of subacute sclerosing panencephalitis: a case report.
Han CY; Lin HF; Shin PY; Liu CK; Liu CS
Kaohsiung J Med Sci; 2003 Aug; 19(8):416-20. PubMed ID: 12962429
[TBL] [Abstract][Full Text] [Related]
9. [Five patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon and inosinpranobex].
Oshiro S; Minema H; Shiroma N; Hirayasu K; Nakada Y
No To Hattatsu; 2004 Jan; 36(1):70-4. PubMed ID: 14737868
[TBL] [Abstract][Full Text] [Related]
10. [Anti SSPE drugs].
Hosoya M
Nihon Rinsho; 2012 Apr; 70(4):625-8. PubMed ID: 22568144
[TBL] [Abstract][Full Text] [Related]
11. Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex.
Le Cras R; Mazet R; Dubois-Teklali F; Sabourdy C; Chanoine S; Lehmann A; Morin A; Leenhardt J; Durand M; Desruet MD; Bedouch P
Emerg Microbes Infect; 2023 Dec; 12(1):2148563. PubMed ID: 36458570
[TBL] [Abstract][Full Text] [Related]
12. Inosiplex affects the spectra of proton magnetic resonance spectroscopy in subacute sclerosing panencephalitis.
Kato Z; Asano T; Kondo N
J Child Neurol; 2006 Feb; 21(2):177-8. PubMed ID: 16566890
[TBL] [Abstract][Full Text] [Related]
13. [Serious complications of intraventricular interferon-alpha and ribavirin in the treatment of subacute sclerosing panencephalitis].
Sato K; Nakagawa E; Nonoda Y; Arai A; Sakuma H; Komaki H; Sugai K; Sasaki M
No To Hattatsu; 2009 May; 41(3):224-8. PubMed ID: 19517795
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis.
Hosoya M; Mori S; Tomoda A; Mori K; Sawaishi Y; Kimura H; Shigeta S; Suzuki H
Antimicrob Agents Chemother; 2004 Dec; 48(12):4631-5. PubMed ID: 15561836
[TBL] [Abstract][Full Text] [Related]
15. Inosiplex in the treatment of subacute sclerosing panencephalitis.
Silverberg R; Brenner T; Abramsky O
Arch Neurol; 1979 Jun; 36(6):374-5. PubMed ID: 88215
[TBL] [Abstract][Full Text] [Related]
16. Beta-interferon plus inosiplex in the treatment of subacute sclerosing panencephalitis.
Anlar B; Yalaz K; Köse G; Saygi S
J Child Neurol; 1998 Nov; 13(11):557-9. PubMed ID: 9853649
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta, interleukin-1 receptor antagonist levels in patients with subacute sclerosing panencephalitis and the effects of different treatment protocols.
Haspolat S; Anlar B; Köse G; Coskun M; Yegin O
J Child Neurol; 2001 Jun; 16(6):417-20. PubMed ID: 11417607
[TBL] [Abstract][Full Text] [Related]
18. [Subacute sclerosing panencephalitis (SSPE)].
Hosoya M
Rinsho Shinkeigaku; 2011 Nov; 51(11):1047-50. PubMed ID: 22277474
[TBL] [Abstract][Full Text] [Related]
19. Role of CSF serology in follow-up of subacute sclerosing panencephalitis patients on treatment.
Gupta E; Dar L; Singh S; Behari M; Broor S
Indian J Med Microbiol; 2006 Apr; 24(2):131-2. PubMed ID: 16687866
[TBL] [Abstract][Full Text] [Related]
20. [Trial of intraventricular ribavirin and interferon-alpha combination therapy for subacute sclerosing panencephalitis (SSPE) in Japan].
Tomoda A; Nomura K; Shiraishi S; Miike T; Hamada A; Hosoya M
No To Hattatsu; 2003 Jul; 35(4):321-6. PubMed ID: 12875209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
